PEOPLE - Nuvelo makes appointment:
This article was originally published in Clinica
Executive Summary
Nuvelo, previously Hyseq Pharmaceuticals, has elected Burton Sobel to its board of directors, effective immediately. Dr Sobel - a professor at the University of Vermont - succeeds Philippe Chambon, who resigned recently. The Sunnyvale, California-based firm, which focuses on cardiovascular products and acute peripheral arterial and catheter occlusion, merged with Variagenics in January 2003 (see Clinica No 1043, p 14).